Orthocell Appoints Exclusive Remplirβ’ Distributor for US$84 Million Thai Nerve Repair Market
Get your Free Report on Top 5 ASX stocks for 2025
Orthocell Limited (ASX: OCC) announced on 03 July 2026 that it has appointed MediTime as the exclusive in-country distributor for Remplir in Thailand, marking a strategic step into the US$84 million Thai nerve repair market.
The appointment follows regulatory approval from the Thailand FDA to commercialise Remplir in the country giving Orthocell a direct pathway to a healthcare market supported by a developed hospital network and strong medical tourism activity. Thailand is a meaningful addition to Orthocellβs Asian expansion strategy, especially given the local demand for advanced nerve repair solutions.
MediTime is a specialist orthopaedics and sports medicine distributor with established reach across hospitals, medical schools and regional centres in Thailand. It is backed by the broader regional infrastructure and commercial expertise of Device Technologies Group and it is Orthocellβs existing partner in Australia, New Zealand and Singapore. This appointment extends a relationship that has already delivered commercial progress across multiple markets.
Orthocell noted that MediTimeβs clinical education model, surgeon relationships, hospital access and national logistics network should help drive engagement among orthopaedic and plastic surgeons and support faster Remplir adoption. The company also highlighted that the distributor led approach allows it to scale in non U.S. markets while keeping internal resources focused on the U.S. opportunity.
That U.S. market remains a major priority with recent approvals expanding access to around 336 hospitals including 221 U.S. military medical centres. Orthocell also noted it remains well funded as it holds more than A$48 million in cash and no debt as at 31 March 2026, which supports ongoing commercial expansion.
(Source: Company Reports)
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether itβs appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
Feature News
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialRecent News
Electro Optic Systems Holdings Secures New Middle ..
Forrestania Secures A$310M for Edna May Acquisitio..
Mithril Silver and Gold Limited Reports Significan..
Ballymore Resources Reports Expanded Survey Identi..
Regis Resources Limited Confirms Growth Potential ..